Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (15 ops.)
Latest filing published 26 Feb 2026 for Vertex Pharmaceuticals INC / MA, €276k.
Filing timeline
BuySaleEdward Morrow Atkinson III
Insider track record
Disclosed buys
0
Disclosed sells
15
Signal history
Edward Morrow Atkinson III: trading record in brief
Edward Morrow Atkinson III appears in 21 filings between March 3, 2023 and February 26, 2026, for two companies: Vertex Pharmaceuticals INC / MA (19 filings, EVP, Chief Technical Ops. Off.) and 89bio, Inc. (2, as Director). The pace settled at 7 filings in 2024 and again in 2025, after 2 in 2023.
Only two sales, both at Vertex: EUR 935,357 on November 17, 2025 and EUR 468,454 on February 21, 2024, for EUR 1.4 million in total. There is no purchase. The large majority of lines are share grants (17), completed by 2 option exercises.
Over the last twelve months, 6 filings are recorded, including the sale of November 2025. Filings are published a median of 2 days after the trade, across 21 dated filings.
Within 30 days of colleagues at Vertex Pharmaceuticals INC / MA, Atkinson III has 2, 1 and 1 own market trades, in that order. All of them in the same direction. Colleagues in order: Ourania Tatsis, Amit Sachdev and Charles F. Wagner Jr..
Companies and markets linked to Edward Morrow Atkinson III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations40 total
668 shares@ US$486.351.3% of flowCommon StockSEC:0000875320-26-000106:1
1,627 shares@ US$485.1124.5% of flowCommon StockSEC:0000875320-26-000106:0
1,530 shares@ US$483.753.0% of flowCommon StockSEC:0000875320-26-000082:1
2,031 shares@ US$489.464.0% of flowCommon StockSEC:0000875320-26-000082:2
817 shares@ US$473.681.6% of flowCommon StockSEC:0000875320-26-000082:3
4,962 shares0Common StockSEC:0000875320-26-000082:0
1,903 shares@ US$487.7628.6% of flowCommon StockSEC:0000875320-26-000060:0
1,751 shares@ US$460.433.2% of flowCommon StockSEC:0000875320-26-000038:1
872 shares@ US$468.4112.6% of flowCommon StockSEC:0000875320-26-000038:0
3,883 shares0Common StockSEC:0000875320-26-000012:1
3,934 shares0Common StockSEC:0000875320-26-000012:0
2,500 shares@ US$434.5834.3% of flowCommon StockSEC:0000875320-25-000236:0
2,650 shares@ US$475.345.7% of flowCommon StockSEC:0000875320-25-000127:1
2,482 shares@ US$479.6114.0% of flowCommon StockSEC:0000875320-25-000127:0
1,767 shares@ US$480.953.9% of flowCommon StockSEC:0000875320-25-000107:1
1,656 shares@ US$483.289.5% of flowCommon StockSEC:0000875320-25-000107:0
1,529 shares@ US$463.468.4% of flowCommon StockSEC:0000875320-25-000083:0
6,211 shares0Common StockSEC:0000875320-25-000061:0
876 shares@ US$467.984.9% of flowCommon StockSEC:0000875320-25-000037:0
1,747 shares@ US$459.833.7% of flowCommon StockSEC:0000875320-25-000037:1
4,744 shares0Common StockSEC:0000875320-25-000011:1
5,132 shares0Common StockSEC:0000875320-25-000011:0
7,288 shares@ US$478.0015.3% of flowCommon StockSEC:0000875320-24-000174:1
6,824 shares@ US$481.9637.9% of flowCommon StockSEC:0000875320-24-000174:0
14,112 shares0Common StockSEC:0000875320-24-000144:0
25 of 40 declarations
